Susvimo can help people with diabetic retinopathy (DR) maintain their vision and prevent progression to blindness with only ...

Ophthalmology Times - ophthalmology news, articles, and events in a timely and accurate manner for members of the ophthalmic ...

The Food and Drug Administration (FDA) has approved Susvimo ® (ranibizumab injection) for the treatment of patients with ...

Susvimo is the first and only FDA-approved, continuous delivery treatment shown to maintain vision in people with DR with ...

Basel: Roche has received approval from the US Food and Drug Administration (FDA) for Susvimo (ranibizumab injection) 100 ...

Susvimo is also approved to treat diabetic macular edema and age-related macular degeneration, and the medication, ...

One-year results from the Pavilion study showed patients who received Susvimo (ranibizumab) refilled every nine months ...

Background: This study was performed to assess the prevalence of dry eye syndrome and diabetic retinopathy (DR) in type 2 diabetic patients and their contributing factors. Methods: 199 type 2 ...

Fear is a natural response when something threatens your vision—but it’s also a signal to act quickly. Some retinal ...

The FDA approved Susvimo 100 mg/mL to treat diabetic retinopathy, according to a press release from Genentech.The approval was supported by positive 1-year data from the phase 3 Pavilion study in ...

Diabetic retinopathy is a serious eye disease caused by diabetes, where high blood sugar levels damage the blood vessels in the retina, potentially leading to vision loss or blindness if left ...